Tempus AI has reported impressive growth, but some of the volatile quarterly numbers have chased off aggressive investors.

Tempus AI, Inc. TEM is scheduled to report first-quarter fiscal 2025 results on May 6. In the last reported quarter, the company’s adjusted loss of 18 cents was wider than the Zacks Consensus Estimate ...

The Tempus 2 is the second iteration of Saucony ... and forefoot is what gives the shoe its responsiveness. A bend test demonstrates just how responsive the midsole is, offering a noticeable ...

The Tempus 2 is the second iteration of Saucony’s niche ... The stiffness and rigidity at the midfoot and forefoot is what gives the shoe its responsiveness. A bend test demonstrates just how ...

Commvault, a leading provider of cyber resilience and data protection solutions for the hybrid cloud, today announced highly differentiated capabilities with its Cleanroom Recovery offering that usher ...

On Thursday, Cathie Wood-led Ark Invest made notable trades, prominently featuring Tempus AI and Coinbase Global ... uses a recruiter-approved coffee cup test in every interview—and he won ...

US-based Tempus has built a precision medicine platform ... and accelerating recruitment of test subjects. The two companies have been working together for some time. In January, for example ...

Using liquid biopsies to test for ESR1 mutations in breast cancer is more feasible for patients and has quicker turnaround times.

The message that Ainnova’s CEO, Vinicio Vargas, continues to convey to audiences around the world is that this accessible, fast, and scalable solution is designed to support early intervention and ...

The in-vitro diagnostics market is projected to experience positive revenue growth due to factors such as the rising incidence of infectious diseases like COVID-19, an increasing prevalence of various ...

From just two retinal images, blood pressure and some lab test information, the system will assess risks ... Illumina Inc. (NASDAQ: ILMN) and Tempus AI, Inc. (NASDAQ: TEM) recently announced a ...